China has approved early-stage human tests for two
experimental coronavirus vaccines.
State news agency Xinhua reported the breakthrough on
Tuesday.
The vaccines are being developed by Sinovac Biotech and by
the Wuhan Institute of Biological Products, an affiliate of state-owned China
National Pharmaceutical Group.
China’s National Health Commission has confirmed the trials
will go ahead.
Work on the trials on the global pandemic commenced in March
2020.
“We can confirm now that three particular vaccines are being
tested in China, and the National Health Commission has said it will have to
clear several conditions before they can enable mass production of the vaccines
globally,” Al-Jazeera’s Sarah Clarke reported.
“A total of 500 people signed up to volunteer for that in
the first phase, which looked at the safety of this vaccine, and the second
phase has now introduced a placebo control group,” she said.
Coronavirus has claimed over 120,000 lives and affected nearly
2 million people.
On Monday, China reported the highest number of new
coronavirus cases in over five weeks.
The country is battling to prevent more COVID-19 infections,
weeks after containing the outbreak.
No comments
Post a Comment
Kindly drop a comment below.
(Comments are moderated. Clean comments will be approved immediately)
Advert Enquires - Reach out to us at NigerianEye@gmail.com